UK markets close in 5 hours 51 minutes

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
24.95+0.78 (+3.23%)
At close: 04:00PM EDT
25.25 +0.30 (+1.20%)
Pre-market: 05:09AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.81B
Enterprise value 26.62B
Trailing P/E 14.98
Forward P/E 11.00
PEG ratio (5-yr expected) 0.74
Price/sales (ttm)0.73
Price/book (mrq)0.99
Enterprise value/revenue 1.48
Enterprise value/EBITDA 7.71

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-40.35%
S&P500 52-week change 3-8.83%
52-week high 342.13
52-week low 323.29
50-day moving average 329.66
200-day moving average 332.37

Share statistics

Avg vol (3-month) 3576.24k
Avg vol (10-day) 31.11M
Shares outstanding 5586.05M
Implied shares outstanding 6N/A
Float 8397.29M
% held by insiders 10.00%
% held by institutions 16.50%
Shares short (30 May 2022) 4991.87k
Short ratio (30 May 2022) 42.1
Short % of float (30 May 2022) 4N/A
Short % of shares outstanding (30 May 2022) 40.17%
Shares short (prior month 28 Apr 2022) 4723.8k

Dividends & splits

Forward annual dividend rate 40.71
Forward annual dividend yield 42.43%
Trailing annual dividend rate 31.34
Trailing annual dividend yield 35.54%
5-year average dividend yield 4N/A
Payout ratio 444.81%
Dividend date 326 May 2022
Ex-dividend date 412 May 2022
Last split factor 22:1
Last split date 303 Dec 2012

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 4.89%
Operating margin (ttm)9.57%

Management effectiveness

Return on assets (ttm)3.16%
Return on equity (ttm)8.12%

Income statement

Revenue (ttm)17.96B
Revenue per share (ttm)30.65
Quarterly revenue growth (yoy)8.00%
Gross profit (ttm)5.08B
Net income avi to common (ttm)877.72M
Diluted EPS (ttm)1.57
Quarterly earnings growth (yoy)-36.80%

Balance sheet

Total cash (mrq)1.17B
Total cash per share (mrq)2
Total debt (mrq)13.34B
Total debt/equity (mrq)91.78
Current ratio (mrq)1.26
Book value per share (mrq)22.58

Cash flow statement

Operating cash flow (ttm)2.44B
Levered free cash flow (ttm)1.34B